直接作用抗病毒药物 (DAA) 对慢性型肝炎C患者的抑郁症和认知功能产生积极影响
Tomasz Pawłowski1, Marek Radkowski2, Karol Perlejewski2
1Department of Psychiatry, Wrocław Medical University, Wrocław, Poland.
PloS one
|April 4, 2025
概括
直接作用抗病毒 (DAA) 治疗显著改善慢性型肝炎病毒 (HCV) 感染患者的大脑功能. 这种疗法可以减轻抑郁症,增强认知能力,包括记忆力和执行功能.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 慢性型肝炎病毒 (HCV) 感染与严重的抑郁和认知功能障碍有关.
- 这些神经精神和认知障碍可能会对患者的生活质量和治疗坚持产生负面影响.
研究的目的:
- 评估直接作用抗病毒疗法 (DAA) 对慢性HCV感染患者抑郁症和认知功能的影响.
主要方法:
- 在DAA治疗前和5-6个月后,52名慢性HCV患者接受了心理和神经认知评估.
- 标准化测试用于测量抑郁症 (贝克抑郁 inventory),焦虑症 (州道焦虑 inventory),神经病症 (Eysenck人格 inventory) 和认知功能 (粗的图形流利性测试,威斯康星州的卡片排序测试,的板测试,加利福尼亚州的口头学习测试).
主要成果:
- DAA治疗导致抑郁症得分显著降低 (p < 0.0001).
- 在认知功能中观察到显著的改善,特别是口头学习和记忆 (加利福尼亚口头学习测试,p = 0.0005) 和执行功能 (鲁夫图形流利性测试,p < 0.0001).
- 晚期和轻度肝病组的改善显著,晚期肝病组的改善显著,晚期肝病组的改善更明显.
结论:
- 直接作用的抗病毒疗法在改善慢性HCV感染患者的大脑功能方面非常有效.
- 在慢性HCV相关的神经精神和认知症状方面,DAA治疗具有显著的益处,有助于患者的整体健康.
相关概念视频
Antidepressant Drugs: Overview
333
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
333
Retrovirus Life Cycles
45.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.5K
Negative and Cognitive Symptoms of Schizophrenia
39
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
39
Depression: Overview
201
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
201
Antidepressant Drugs: MAOIs and Other Agents
171
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
171
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
86
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
86


